SENISCA is a spinout company from the University of Exeter, founded in 2020 to develop new approaches to reverse cellular senescence (ageing) and treat diseases and aesthetic aspects of ageing. SENISCA says it has discovered a new and druggable means to reverse senescence through modulation of RNA splicing. The company’s founders have demonstrated that restoration […]

View post to subscribe to site newsletter.

Delonix Bioworks is a Shanghai-based startup using synthetic biology to design bacteria to act as safer and more effective vaccines against bacterial infections and cancer. The Delonix team has developed a novel approach that builds on the established concept of live attenuated bacteria and combines it with the latest developments in synthetic biology. Delonix’s synthetic […]

View post to subscribe to site newsletter.

Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) therapeutics, a new class of RNA medicines with the potential to treat a wide range of diseases including cancer, autoimmune, and genetic disorders. Built on research from Prof. Daniel Anderson’s lab at MIT, oRNA is described by the company as the next revolution […]

View post to subscribe to site newsletter.